The United States is facing a significant drug abuse crisis, yet instead of seeking effective solutions, it has been directing criticism towards China's counter-narcotics efforts.
In a recent presidential memorandum submitted to Congress, U.S. President Joe Biden labeled China as a \"major drug transit or major illicit drug producing country.\" However, this designation lacks foundation when considering the facts. China has classified 456 types of substances as controlled, making it one of the countries with the most stringent drug regulations. Additionally, China regulates 38 precursor chemicals, 14 more than those under United Nations control, according to Chinese Foreign Ministry spokesperson Mao Ning.
Contrastingly, the U.S. consumes a disproportionate amount of drugs globally. Despite representing less than 5 percent of the world population, the U.S. accounts for 80 percent of the opioids produced worldwide. The Centers for Disease Control and Prevention report that over one million Americans have died from drug overdoses since 2000.
The pressing issue of drug abuse in the U.S. calls for a fundamental solution. Unfortunately, American politicians appear more interested in blaming China to vent societal frustrations rather than addressing the root causes of illegal drug use. This approach seems driven by the desire for economic and political gains rather than genuine efforts to eradicate drug abuse.
From an economic perspective, drug legalization presents a potential boost in tax revenues. For instance, Colorado, one of the first states to legalize recreational marijuana, collected $325 million in cannabis tax revenue in 2022. During the COVID-19 pandemic, while other states struggled, Colorado benefited financially from its cannabis taxes.
Reference(s):
cgtn.com
